Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Research and development spending
3Y CAGR
+35.8%/yr
Annual compound
5Y CAGR
+100.1%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
32.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $59.99M | -6.3% |
| 2024 | $63.99M | +40.7% |
| 2023 | $45.49M | +89.9% |
| 2022 | $23.95M | +74.6% |
| 2021 | $13.72M | +633.6% |
| 2020 | $1.87M | - |